| 1. | 813kimd | |
| 2. | hal8558 | |
| 3. | willster76 | |
| 4. | etbubba | |
| 5. | jpanman11 |
Top Board Researchers
These are the top researchers based on quality of posts as voted by board members. Typically they know their stuff and are a great
way to catch up on what the company is all about.
HOW DO I BECOME ONE?
Just do great research! As other members approve of your posts, you earn points that move you up the ranks.| 1. | willster76 05/03/2018 Beats EPS loss estimates by $0.13. Misses on revenues. |
| 2. | 813kimd 03/07/2018 Took a bigger position yesterday and feel the news |
| 3. | hal8558 01/25/2018 DD |
| 4. | 813kimd 09/28/2017 $EDIT wouldn't it be incredible if this got one of the Allergan milestone installments in the near future? |
| 5. | etbubba 01/09/2018 Breaking News: |
| 6. | willster76 09/28/2017 Edit-101 is the drug approved in Europe for the eye disease treatment. |
| 7. | 813kimd 03/07/2018 Editas Medicine Announces Fourth Quarter and Full Year 2017 Results and Update |
NEW since the last time you visited this board.
Currently a TOP 10 POST for this board.
Currently a TOP 5 RESEARCHER for this board.
Specific post has replies to it.
A Researcher you are currently FOLLOWING
Other Researchers rate this post HIGH
Other Researchers rate this post LOW
Editas Medicine, Inc.
- EDIT
- Public Stock Message Board
Filtering by:
-
To use your chart in a post, click the
icon above the chart. From there you can get the chart link or download the image.